Organism name | Cedrus libani |
---|---|
Genus | Cedrus |
Family | Pinaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Cedrus libani |
---|---|
Linked NCBI taxonomy ID | 93692 |
Linked level | species |
Family in NCBI taxonomy | Pinaceae |
---|---|
ID | 3318 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | Spermatophyta |
---|---|
ID | 58024 |
Species | Activity |
---|---|
Cedrus libani A. Rich. | Diuretic |
Cedrus libani A. Rich. | Expectorant |
Cedrus libani A. Rich. | Fungicide |
Cedrus libani A. Rich. | Insecticide |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00003162
![]() |
Longifolene
|
CHEMBL519092
|
C035607
|
No. 149 | No. 38 |
![]() |
||
C00029421
![]() |
epi-Cubenol
/ 1-epi-Cubenol / (+)-ent-Epicubenol |
No. 205 | No. 38 |
![]() |
||||
C00022712
![]() |
Manool
|
CHEMBL561922
|
No. 256 | No. 46 |
![]() |
|||
C00029866
![]() |
Cubenene
/ Cadina-1,4-diene / Cadina-1(2),4-diene |
No. 283 | No. 39 |
![]() |
||||
C00030345
![]() |
gamma-Cadinene
|
C054278
|
No. 283 | No. 39 |
![]() |
|||
C00029671
![]() |
alpha-Muurolene
|
No. 283 | No. 39 |
![]() |
||||
C00020130
![]() |
gamma-Muurolene
/ 1beta-Cadina-4,10(15)-diene |
No. 283 | No. 39 |
![]() |
||||
C00035828
![]() |
gamma-Amorphene
/ (+)-gamma-Amorphene |
No. 283 | No. 39 |
![]() |
||||
C00003203
![]() |
alpha-Ylangene
|
No. 333 | No. 38 |
![]() |
||||
C00048329
![]() |
beta-Copaene
|
No. 333 | No. 38 |
![]() |
||||
C00003120
![]() |
alpha-Cubebene
|
No. 333 | No. 38 |
![]() |
||||
C00003118
![]() |
Copaene
/ alpha-Copaene / (-)-alpha-Copaene |
No. 333 | No. 38 |
![]() |
||||
C00029977
![]() |
cis-Verbenol
|
No. 476 | No. 35 |
![]() |
||||
C00000805
![]() |
alpha-Pinene
|
CHEMBL442565
|
C005451
|
3 / 3 / 2 | 0 / 1 | No. 476 | No. 35 |
![]() |
C00000816
![]() |
beta-Pinene
|
CHEMBL501351
|
C010789
|
No. 476 | No. 35 |
![]() |
||
C00000829
![]() |
trans-Pinocarveol
|
No. 476 | No. 35 |
![]() |
||||
C00021309
![]() |
alpha-Himachalene
|
No. 478 | No. 38 |
![]() |
||||
C00003110
![]() |
Caryophyllene
/ (E)-Caryophyllene / beta-Caryophyllene / (-)-(E)-Caryophyllene / (E)-beta-Caryophyllene |
CHEMBL445740
CHEMBL448700 |
2 / 3 / 7 | No. 478 | No. 38 |
![]() |
||
C00021310
![]() |
gamma-Himachalene
|
No. 478 | No. 38 |
![]() |
||||
C00003145
![]() |
Himachalol
|
C010185
|
0 / 2 | No. 615 | No. 38 |
![]() |
||
C00000823
![]() |
Limonene
|
CHEMBL15799
CHEMBL449062 |
C008281
|
7 / 21 / 48 | 6 / 6 | No. 848 | No. 35 |
![]() |
C00029674
![]() |
alpha-Terpineol
|
CHEMBL447597
CHEMBL449810 |
C016775
|
3 / 16 / 11 | No. 983 | No. 35 |
![]() |
|
C00001221
![]() |
Lauric acid
/ Docosanoic acid / n-Dodecanoic acid |
CHEMBL108766
|
C030358
|
19 / 25 / 14 | 11 / 0 | No. 1141 | No. 68 |
![]() |
C00021899
![]() |
Allohimachalol
|
No. 1295 |
![]() |
|||||
C00050259
![]() |
trans-alpha-Bisabolene
|
No. 1323 | No. 38 |
![]() |
||||
C00003147
![]() |
Humulene
/ alpha-Caryophyllene / (+/-)-alpha-Humulene |
CHEMBL251280
|
C042686
|
No. 1421 | No. 38 |
![]() |
||
C00050265
![]() |
Z-gamma-Atlantone
|
No. 1469 | No. 38 |
![]() |
||||
C00050146
![]() |
Longiborneol
|
C412581
|
No. 1507 |
![]() |
||||
C00007631
![]() |
Abietadiene
|
No. 1536 | No. 40 |
![]() |
||||
C00010872
![]() |
beta-Phellandrene
/ (+/-)-beta-Phellandrene |
CHEMBL444254
|
C058582
|
No. 1898 | No. 35 |
![]() |
||
C00029544
![]() |
4-Terpineol
/ Terpin-4-ol / Terpineol-4 / Terpinen-4-ol |
CHEMBL507795
|
C034019
|
1 / 3 / 0 | No. 2215 |
![]() |
||
C00011897
![]() |
Atlantonic acid
|
No. 2249 |
![]() |
|||||
C00000853
![]() |
Myrcene
|
CHEMBL455491
|
C008574
|
3 / 3 / 3 | No. 2285 | No. 34 |
![]() |
|
C00003029
![]() |
Camphene
|
CHEMBL506889
CHEMBL510535 |
C019286
|
No. 2460 | No. 35 |
![]() |
||
C00003061
![]() |
gamma-Terpinene
/ 1-Methyl-4-(1-methylethyl)-1,4-cyclohexadiene |
CHEMBL449693
|
C018669
|
No. 2468 | No. 35 |
![]() |
||
C00003060
![]() |
alpha-Terpinene
|
No. 2468 | No. 35 |
![]() |
||||
C00011720
![]() |
Germacrene D
/ (-)-Germacrene D |
CHEMBL105432
CHEMBL1836650 |
No. 2639 | No. 38 |
![]() |
|||
C00011045
![]() |
delta-3-Carene
/ (-)-Carene(-)-3-Carene |
CHEMBL506854
|
No. 2690 | No. 35 |
![]() |
|||
C00011903
![]() |
(+)-Todomatuic acid
|
No. 2790 |
![]() |
|||||
C00011891
![]() |
Libanotic acid
|
No. 2790 |
![]() |
|||||
C00000861
![]() |
Terpinolene
|
CHEMBL454697
|
C027009
|
1 / 0 | No. 3725 |
![]() |
||
C00050104
![]() |
gamma-Dehydro-ar-himachalene
|
No. 4291 |
![]() |
|||||
C00021308
![]() |
beta-Himachalene
|
No. 7393 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00001221 C00029544 C00029674 | 3 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000805 C00000853 C00001221 | 3 / 2 |
Q96RI1 | Bile acid receptor | NR1H4 | C00000853 C00001221 | 0 / 0 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000805 C00001221 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00000823 C00001221 | 3 / 1 |
P02545 | Prelamin-A/C | Unclassified protein | C00000823 C00029674 | 11 / 10 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00000823 C00001221 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001221 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000823 | 0 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001221 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00001221 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00001221 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001221 | 7 / 3 |
Q9UGP5 | DNA polymerase lambda | Enzyme | C00001221 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000823 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000853 | 0 / 1 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00001221 | 5 / 3 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00001221 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000805 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000823 | 7 / 37 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00001221 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00001221 | 1 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001221 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00029674 | 5 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000823 | 0 / 0 |
P10275 | Androgen receptor | NR3C4 | C00001221 | 3 / 4 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001221 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00003110 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00003110 | 1 / 2 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000823
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000823
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000823
|
3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00000823
|
4852 | NPY, PYY4 | neuropeptide Y |
C00000823
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000823
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000861
|
128 | ADH5, ADH-3, ADHX, FALDH, FDH, GSH-FDH, GSNOR | alcohol dehydrogenase 5 (class III), chi polypeptide (EC:1.1.1.1 1.1.1.284) |
C00001221
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00001221
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00001221
|
1579 | CYP4A11, CP4Y, CYP4A2, CYP4AII | cytochrome P450, family 4, subfamily A, polypeptide 11 (EC:1.14.15.3) |
C00001221
|
199974 | CYP4Z1, CYP4A20 | cytochrome P450, family 4, subfamily Z, polypeptide 1 (EC:1.14.14.1) |
C00001221
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001221
|
64127 | NOD2, ACUG, BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, NOD2B, PSORAS1 | nucleotide-binding oligomerization domain containing 2 |
C00001221
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00001221
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001221
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001221
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00001221
|
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
%606641 | Body mass index; bmi |
P37231
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#601665 | Obesity |
P37231
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P35354 (related) |
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
P35354 (related) |
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D003877 | Dermatitis, Contact |
C00000805
C00000823 |
D008569 | Memory Disorders |
C00000823
|
D008107 | Liver Diseases |
C00000823
|
D008114 | Liver Neoplasms, Experimental |
C00000823
|
D007674 | Kidney Diseases |
C00000823
|
D013276 | Stomach Ulcer |
C00000823
|
D007022 | Hypotension |
C00003145
|
D013035 | Spasm |
C00003145
|